Page last updated: 2024-11-04

terbutaline and Ehlers-Danlos Syndrome

terbutaline has been researched along with Ehlers-Danlos Syndrome in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Ehlers-Danlos Syndrome: A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Athanassiou, AM1
Turrentine, MA1

Other Studies

1 other study available for terbutaline and Ehlers-Danlos Syndrome

ArticleYear
Myocardial infarction and coronary artery dissection during pregnancy associated with type IV Ehlers-Danlos syndrome.
    American journal of perinatology, 1996, Volume: 13, Issue:3

    Topics: Adult; Aortic Dissection; Contraindications; Coronary Aneurysm; Ehlers-Danlos Syndrome; Female; Huma

1996